DaVita, Inc. (DVA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1153062,
    "name": "DaVita, Inc.",
    "stock_name": "DaVita, Inc.",
    "full_name": "DaVita, Inc.",
    "name_url": "stocks-analysis/davita-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "117.28",
    "chg": -0.97,
    "chgp": "-0.82%",
    "dir": -1,
    "prev_price": "118.25",
    "mcapval": "10,659.92",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 3365,
    "indexname": "S&P 500",
    "isin": "US23918K1088",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.32 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/davita-inc-1153062-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "DaVita, Inc. Hits New 52-Week Low at USD 117.73",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/davita-inc-hits-new-52-week-low-at-usd-11773-3661884",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/DaVitaInc_priceRelatedfactors_3661884.png",
        "date": "2025-10-31 16:01:18",
        "description": "DaVita, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of approximately USD 10.66 billion, faces financial challenges, including a negative book value and a high debt-to-equity ratio, raising concerns about its market position."
      },
      {
        "title": "DaVita, Inc. Hits 52-Week Low at USD 122.92 Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/davita-inc-hits-52-week-low-at-usd-12292-amid-financial-struggles-3620082",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/DaVitaInc_priceRelatedfactors_3620082.png",
        "date": "2025-10-14 18:40:40",
        "description": "DaVita, Inc. has hit a new 52-week low, reflecting a notable decline in its stock price over the past year. The company faces financial challenges, including a negative book value and a high debt-to-equity ratio, despite a modest growth rate in operating profit over the last five years."
      },
      {
        "title": "DaVita, Inc. Stock Plummets to New 52-Week Low of $123.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/davita-inc-stock-plummets-to-new-52-week-low-of-12315-3617597",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/DaVitaInc_priceRelatedfactors_3617597.png",
        "date": "2025-10-13 17:30:41",
        "description": "DaVita, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces financial challenges, including a negative book value and a high debt-to-equity ratio. Its performance has lagged behind broader market trends, indicating ongoing difficulties."
      },
      {
        "title": "Is DaVita, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-davita-inc-technically-bullish-or-bearish-3545543",
        "imagepath": "",
        "date": "2025-09-20 19:13:50",
        "description": "As of 10 September 2025, the technical trend for DaVita, Inc. has changed from mildly bearish to bearish. The weekly MACD is bearish, and the daily moving averages also indicate a bearish stance. Bollinger Bands confirm a bearish trend on both weekly and monthly time frames. The KST shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, while the Dow Theory indicates a mildly bearish trend on the weekly with no trend on the monthly. The OBV is mildly bearish across both time frames.\n\nIn terms of performance, DaVita has underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -12.92% versus the S&P 500's 12.22%, and a one-year return of -20.18% compared to the S&P 500's 17.14%. Overall, the current technical stance is bearish, reflecting weakness in the indicators...."
      },
      {
        "title": "Is DaVita, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-davita-inc-overvalued-or-undervalued-3542243",
        "imagepath": "",
        "date": "2025-09-20 17:48:15",
        "description": "As of 12 May 2025, the valuation grade for DaVita, Inc. has moved from attractive to risky, indicating a shift towards a more negative outlook. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 10, an EV to EBITDA ratio of 7.83, and a PEG ratio of 0.75, which suggests that despite a low P/E, the overall valuation does not support a favorable investment case given the risks involved.\n\nIn comparison to its peers, DaVita's P/E ratio of 9.71 is significantly lower than Encompass Health Corp. at 20.94 and The Ensign Group, Inc. at 32.46, both of which are rated attractive. Additionally, the company's return performance has lagged behind the S&P 500, with a year-to-date return of -12.92% compared to the index's 12.22%, and a one-year return of -20.18% versus 17.14%. This underperformance reinforces the notion that DaVita, Inc. is currently overvalued in the market..."
      }
    ],
    "total": 10,
    "sid": "1153062",
    "stock_news_url": "https://www.marketsmojo.com/news/davita-inc-1153062"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

DaVita, Inc. Hits New 52-Week Low at USD 117.73

2025-10-31 16:01:18

DaVita, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of approximately USD 10.66 billion, faces financial challenges, including a negative book value and a high debt-to-equity ratio, raising concerns about its market position.

DaVita, Inc. Hits 52-Week Low at USD 122.92 Amid Financial Struggles

2025-10-14 18:40:40

DaVita, Inc. has hit a new 52-week low, reflecting a notable decline in its stock price over the past year. The company faces financial challenges, including a negative book value and a high debt-to-equity ratio, despite a modest growth rate in operating profit over the last five years.

DaVita, Inc. Stock Plummets to New 52-Week Low of $123.15

2025-10-13 17:30:41

DaVita, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces financial challenges, including a negative book value and a high debt-to-equity ratio. Its performance has lagged behind broader market trends, indicating ongoing difficulties.

Is DaVita, Inc. technically bullish or bearish?

2025-09-20 19:13:50

As of 10 September 2025, the technical trend for DaVita, Inc. has changed from mildly bearish to bearish. The weekly MACD is bearish, and the daily moving averages also indicate a bearish stance. Bollinger Bands confirm a bearish trend on both weekly and monthly time frames. The KST shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, while the Dow Theory indicates a mildly bearish trend on the weekly with no trend on the monthly. The OBV is mildly bearish across both time frames. In terms of performance, DaVita has underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -12.92% versus the S&P 500's 12.22%, and a one-year return of -20.18% compared to the S&P 500's 17.14%. Overall, the current technical stance is bearish, reflecting weakness in the indicators....

Is DaVita, Inc. overvalued or undervalued?

2025-09-20 17:48:15

As of 12 May 2025, the valuation grade for DaVita, Inc. has moved from attractive to risky, indicating a shift towards a more negative outlook. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 10, an EV to EBITDA ratio of 7.83, and a PEG ratio of 0.75, which suggests that despite a low P/E, the overall valuation does not support a favorable investment case given the risks involved. In comparison to its peers, DaVita's P/E ratio of 9.71 is significantly lower than Encompass Health Corp. at 20.94 and The Ensign Group, Inc. at 32.46, both of which are rated attractive. Additionally, the company's return performance has lagged behind the S&P 500, with a year-to-date return of -12.92% compared to the index's 12.22%, and a one-year return of -20.18% versus 17.14%. This underperformance reinforces the notion that DaVita, Inc. is currently overvalued in the market...

View All News